Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: Role of apolipoprotein A-I

Journal of Lipid Research

Volumn 38, Issue 3, 1997, Pages 516-525

  Massamiri, Tania ^a   Tobias, Peter S ^a   Curtiss, Linda K ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

acute phase; endotoxins; epitopes; septic shock

Indexed keywords

APOLIPOPROTEIN A1; BINDING PROTEIN; LIPOPOLYSACCHARIDE;

ACUTE PHASE RESPONSE; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL SUBPOPULATION; DRUG EFFECT; HUMAN; HUMAN CELL; LIGAND BINDING; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SEPTIC SHOCK; STRUCTURE ANALYSIS;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; APOLIPOPROTEIN A-I; BIOTIN; CARRIER PROTEINS; CHO CELLS; CRICETINAE; CULTURE MEDIA, CONDITIONED; EPITOPES; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; MEMBRANE GLYCOPROTEINS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 0030897425     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lynn, W. A., and J. Cohen. 1995. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 20: 143-158.
2. Epstein, F. H. 1993. Mechanisms of disease. N. Engl. J. Med. 328: 1471-1477.
3. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115: 457-469.
4. Parrillo, J. E. 1993. Pathogenenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477.
5. Froon, A. H., M. A. Dentener, J. W. Greve, G. Ramsay, and W. A. Buurman. 1995. Lipopolysaccharide toxicity-regulating proteins in bacteremia. J. Infect. Dis. 171: 1250-1257.
6. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249: 1431-1433.
7. Weiss, J., P. Elsbach, I. Olsson, and H. Odeberg. 1978: Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J. Biol. Chem. 253: 2664-2672.
8. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1981. New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J. Clin. Invest. 67: 827-837.
9. Pugin, J., C.-C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA. 90: 2744-2748.
10. Tobias, P. S., J. C. Mathison, and R. J. Ulevitch. 1988. A family of lipopolysaccharide binding proteins involved in responses to gram negative sepsis. J. Biol. Chem. 263: 13479-13481.
11. Su, G. L., R. L. Simmons, and S. C. Wang. 1995. Lipopolysaccharide binding protein participation in cellular activation by LPS. Crit. Rev. Immunol. 15: 201-214.
12. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164: 777-793.
13. Cavaillon, J.-M., C. Fitting, N. Haeffner-Cavaillon, S. J. Kirsch, and H. S. Warren. 1990. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect. Immun. 58: 2375-2382.
14. Flegel, W. A., M. W. Baumstark, C. Weinstock, A. Berg, and H. Northoff. 1993. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect. Immun. 61: 5140-5146.
15. Van Lenten, B. J., A. M. Fogelman, M. E. Haberland, and P. A. Edwards. 1986. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 83: 2704-2708.
16. Hubsch, A. P., F. S. Powell, P. G. Lerch, and J. E. Doran. 1993. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ. Shock. 40: 14-23.
17. Read, T. E., C. Grunfeld, Z. Kumwenda, M. Calhoun, J. P. Kane, K. R. Feingold, and J. H. Rapp. 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182: 267-272.
18. Munford, R. S., J. M. Andersen, and J. M. Dietsch. 1981. Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. J. Clin. Invest. 68: 1503-1513.
19. Munford, R. S., C. L. Hall, and J. M. Dietschy. 1981. Binding of Salmonella typhimurium lipopolysaccharides to rat high density lipoproteins. Infect. Immun. 34: 835-843.
20. Parker, T. S., D. M. Levine, J. C. C. Chang, J. Laxer, C. C. Coffin, and A. L. Rubin. 1995. Reconstituted high density lipoprotein neutralizes gram negative bacterial lipopolysaccharides in human whole blood. Infect. Immun. 63: 253-258.
21. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90: 12040-12044.
22. Tobias, P. S., and R. J. Ulevitch. 1983. Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein. J. Immunol. 131: 1913-1916.
23. Harris, H. W., C. Grunfeld, K. R. Feingold, T. E. Read, J. P. Kane, A. L. Jones, E. B. Eichbaum, G. F. Bland, and J. H. Rapp. 1993. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91: 1028-1034.
24. Wurfel, M. M., S. T. Kunitake, H. Lichenstein, J. P. Kane, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180: 1025-1035.
25. Emancipator, K., G. Csako, and R. J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60: 596-601.
26. Park, T. C., and S. D. Wright. 1996. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and Factor H-related proteins. J. Biol. Chem. 271: 18054-18060.
27. Curtiss, L. K., and T. S. Edgington. 1985. Immunochemical heterogeneity of human plasma high density lipoproteins: identification with apolipoprotein A-I and A-II specific monoclonal antibodies. J. Biol. Chem. 260: 2982-2993.
28. Rye, K., and P. J. Barter. 1994. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. J. Biol. Chem. 269: 10298-10303.
29. Cheung, M. C., J. P. Segrest, J. J. Albers, J. T. Cone, C. G. Brouillette, B. H. Chung, M. Kashyap, M. A. Glasscock, and G. M. Anantharamaiah. 1987. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J. Lipid Res. 28: 913-929.
30. Skinner, E. R. 1994. High density lipoprotein subclasses. Curr. Opin. Lipidol. 5: 241-247.
31. Fruchart, J., G. Ailhaud, and J. Bard. 1993. Heterogeneity of high density lipoprotein particles. Circulation. 87: III-22-III-27.
32. Hayek, T., Y. Ito, N. Azrolan, R. B. Verdery, K. Aalto-Setala, A. Walsh, and J. L. Breslow. 1993. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rate and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (apo)A-I. J. Clin. Invest. 91: 1665-1671.
33. Wilson, H. M., J. C. Patel, and E. R. Skinner. 1990. The distribution of high density lipoprotein subfractions in coronary survivors. Biochem. Soc. Trans. 18: 1175-1176.
34. Wilson, H. M., J. C. Patel, D. Russell, and E. R. Skinner. 1993. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin. Chim. Acta. 220: 175-187.
35. Attman, P., O. Samuelsson, and P. Alaupovic. 1993. Lipoprotein metabolism and renal failure. Am. J. Kidney Dis. 21: 573-592.
36. Tall, A. R. 1990. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 86: 379-384.
37. Brewer, H. B., T. Fairwell, A. LaRue, R. Ronan, A. Houser, and T. J. Bronzert. 1978. The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins. Biochem. Biophys. Res. Commun. 80: 623-630.
38. Gray, P. W., G. W. Flaggs, S. R. Leong, J. Weiss, C. E. Ooi, and P. Elsbach. 1989. Cloning of the cDNA of a human neutrophil bactericidal protein. J. Biol. Chem. 264: 9505-9509.
39. Marcel, Y. L., P. R. Provost, H. Koa, E. Raffai, N. V. Dac, J. Fruchart, and E. Rassart. 1991. The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region. J. Biol. Chem. 266: 3644-3653.
40. Banka, C. L., D. J. Bonnet, A. S. Black, R. S. Smith, and L. K. Curtiss. 1991. Localization of an apolipoprotein A-I epitope critical for activation of lecithin:cholesterol acyltransferase. J. Biol. Chem. 266: 23886-23892.
41. McFarlane, A. S. 1958. Efficient trace-labelling of proteins with iodine. Nature. 182: 53-57.
42. Gegner, J. A., R. J. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance: dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270: 5320-5325.
43. Theofan, G., A. Horwitz, R. E. Williams, P.-S. Liu, I. Chan, C. Birr, S. F. Carrol, K. Meszaros, J. B. Parent, H. Kasler, S. Aberle, P. W. Trown, and H. Gazzano-Santoro. 1994. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A but not CD14-stimulatory activity. J. Immunol. 152: 3623-3629.
44. Curtiss, L. K., and C. L. Banka. 1996. Selection of monoclonal antibodies for linear epitopes of an apolipoprotein yields antibodies with comparable affinity for lipid-free and lipid-associated apolipoprotein. J. Lipid Res. 37: 884-892.
45. Curtiss, L. K., and R. S. Smith. 1988. Localization of two epitopes of apolipoprotein A-I that are exposed on human high density lipoproteins using monoclonal antibodies and synthetic peptides. J. Biol. Chem. 263: 13779-13785.
46. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of tetrapeptide. J. Am. Chem. Soc. 85: 2149-2154.
47. Ulevitch, R. J., and A. R. Johnston. 1978. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J. Clin. Invest. 62: 1313-1324.
48. Vaara, M., and H. Nikaido. 1984. Molecular organization of bacterial outer membrane. In handbook on Endotoxin: Chemistry of Endotoxin. E. T. Rietschel, editor. Elsevier, New York. 1-45.
49. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1979. New function for high density lipoproteins: their participation in intravascular reactions of bacterial lipopolysaccharides. J. Clin. Invest. 64: 1516-1524.
50. Meng, Q., L. Calabresi, J. Fruchart, and Y. L. Marcel. 1993. Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase:importance of the central domain. J. Biol. Chem. 268: 16966-16973.
51. Banka, C. L., A. S. Black, and L. K. Curtiss. 1994. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J. Biol. Chem. 269: 10288-10297.
52. Meng, Q., J. Bergeron, D. L. Sparks, and Y. L. Marcel. 1995. Role of apolipoprotein A-I in cholesterol transfer between lipoproteins: evidence for involvement of specific apoA-I domains. J. Biol. Chem. 270: 8588-8596.